Press Release Summary:
Benefiting both research and screening markets, SpectraMaxÂ® ParadigmÂ® Multi-Mode Microplate Detection Platform with TUNE cartridge provides monochromator-like wavelength flexibility without compromising sensitivity. System is built with on-the-fly detection, plate format of up to 1,536 wells, and dual PMTs. Spectral Optimization Wizard in SoftMaxÂ® Pro software minimizes assay set up time with simultaneous scanning of excitation and emission spectrums.
Original Press Release:
Molecular Devices Releases Breakthrough TUNE Technology, Now Part of the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform
SUNNYVALE, Calif., -- Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced the addition of the TUNE detection cartridge to the SpectraMax Paradigm Multi-Mode Microplate Detection Platform. The breakthrough technology of TUNE with wavelength flexibility in a monochromator device and up to 10x the sensitivity will benefit both the research and screening markets.
The SpectraMax Paradigm Detection Platform is the only user upgradeable microplate reader on the market today. It allows the user to read what they want, when they want. Now, with the TUNE detection cartridge, the Paradigm system is the most flexible instrument available. The patent pending Spectral Optimization Wizard in SoftMax® Pro software reduces the assay set up time by more than 50% with simultaneous scanning of excitation and emission spectrums.
Flexibility for Research
For the researchers who need the wavelength flexibility of a monochromator in fluorescent applications, TUNE will offer unmatched sensitivity allowing them to test new assays and further advance their research. The flexibility of the Paradigm platform and ability to easily add future options, makes it a great investment for their labs.
Speed of Paradigm with Sensitivity of TUNE, Ideal for Screening
The TUNE cartridge enables monochromator-like wavelength flexibility without compromising on sensitivity. The Paradigm platform is built with on-the-fly detection for reduced read times, plate format of up to 1536-wells, dual PMTs, and was designed with automation in mind, all important features for high throughput. Use of the TUNE cartridge with the Paradigm instrument will meet the needs of screeners with high sensitivity and throughput demands.
"We are extremely excited about our TUNE technology, which provides unmatched fluorescence sensitivity with wavelength flexibility. It will open new possibilities to our customers and is a great addition to the SpectraMax Paradigm platform," said Mikey Kindler, Senior Director of BioResearch Marketing.
About Molecular Devices, LLC
At Molecular Devices we have one focus--our customers. Whether a long-time user, recent adopter, or prospective customer, your needs fuel our actions. We hire creative, best-in-class people to design, manufacture, and commercialize analytical instruments, software, and assays as well as provide dedicated follow-on support. Understanding your laboratory workflow is our top priority, and we direct product development toward solving your unique issues. Our instruments offer a full spectrum of detection technologies and meet all throughput needs--from dedicated, single-readout devices to multi-readout systems. Our goal is to deliver highly relevant analytical products to detect biology, decode data, and drive discovery. With headquarters in Silicon Valley and offices around the globe, we support and enrich efforts of the international BioResearch, BioPharma, and BioTesting communities. Visit us today at www.MolecularDevices.com.
Molecular Devices products are for Research Use Only. Not for use in diagnostic procedures.
The trademarks mentioned herein are the property of Molecular Devices, LLC, or their respective owners.
© 2011. Molecular Devices, LLC